Ipca Laboratories Limited (BOM:524494)
1,603.00
+19.35 (1.22%)
At close: Mar 30, 2026
Ipca Laboratories Revenue
Ipca Laboratories had revenue of 23.93B INR in the quarter ending December 31, 2025, with 6.55% growth. This brings the company's revenue in the last twelve months to 95.06B, up 8.93% year-over-year. In the fiscal year ending March 31, 2025, Ipca Laboratories had annual revenue of 89.41B with 16.03% growth.
Revenue (ttm)
95.06B
Revenue Growth
+8.93%
P/S Ratio
4.27
Revenue / Employee
5.67M
Employees
16,778
Market Cap
406.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 89.41B | 12.35B | 16.03% |
| Mar 31, 2024 | 77.06B | 14.58B | 23.33% |
| Mar 31, 2023 | 62.48B | 4.18B | 7.16% |
| Mar 31, 2022 | 58.31B | 4.10B | 7.56% |
| Mar 31, 2021 | 54.21B | 7.71B | 16.58% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 345.83B |
| Lupin | 261.51B |
| Torrent Pharmaceuticals | 127.42B |
| Jubilant Pharmova | 79.18B |
| Abbott India | 68.24B |
| Granules India | 50.92B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |
| GlaxoSmithKline Pharmaceuticals | 38.01B |
Ipca Laboratories News
- 1 day ago - Top stocks to buy: Stock recommendations for March 30, 2026 week - check list - The Times of India
- 8 days ago - Top stocks to buy: Stock recommendations for March 23, 2026 week - check list - The Times of India
- 6 weeks ago - Ipca Laboratories Ltd (BOM:524494) Q3 2026 Earnings Call Highlights: Strong Domestic Growth and ... - GuruFocus
- 6 weeks ago - Q3 2026 IPCA Laboratories Ltd Earnings Call Transcript - GuruFocus
- 6 weeks ago - Ipca Laboratories Q3 Results: Net profit jumps 31.5% YoY to Rs 326.27 crore, revenue up 6.55% - Business Upturn
- 7 weeks ago - Ipca Laboratories receives US FDA VAI status for Tarapur API facility - Business Upturn
- 4 months ago - This brokerage firm advises to Buy IPCA Labs shares and expects nearly 20% upside in stock price - Business Upturn
- 4 months ago - Ipca Laboratories Ltd (BOM:524494) Q2 2026 Earnings Call Highlights: Strong Domestic Growth ... - GuruFocus